Domov › Rak (vse vrste) › Michigan › Grand Rapids
Klinične študije za Rak (vse vrste) v Grand Rapids, MI
28 študij za Rak (vse vrste) išče udeležence na lokacijah v Grand Rapids in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Vključevanje udeležencevFaza 2
- START Midwest ( Site 1103), Grand Rapids
REC-7735 in Participants With Solid Tumors
Vključevanje udeležencevFaza 1/2
- START Midwest, Grand Rapids
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Vključevanje udeležencevFaza 1
- START Midwest /ID# 279035, Grand Rapids
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Vključevanje udeležencevFaza 1/2
- Corewell Health ( Site 4001), Grand Rapids
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Vključevanje udeležencevFaza 1
- Start Midwest, Grand Rapids
A Study of JNJ-87890387 for Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Start Midwest, Grand Rapids
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Vključevanje udeležencevFaza 2
- Cancer Research Consortium of West Michigan, Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- START Midwest, Grand Rapids
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Vključevanje udeležencevFaza 1/2
- Corewell Health ( Site 3001), Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- START - Midwest Cancer Research Center, Grand Rapids
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- The Cancer & Hematology Centers, Grand Rapids
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Vključevanje udeležencevFaza 3
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Vključevanje udeležencevFaza 1
- START Midwest, Grand Rapids
Project: Every Child for Younger Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Site 04, Grand Rapids
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1
- START Midwest, Grand Rapids
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Vključevanje udeležencevFaza 1
- START Midwest, Grand Rapids
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Vključevanje udeležencevFaza 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
- BAMF Health Inc., Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- START Midwest, Grand Rapids
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Vključevanje udeležencevFaza 1/2
- START Midwest, Grand Rapids
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Vključevanje udeležencevFaza 1
- GSK Investigational Site, Grand Rapids
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Vključevanje udeležencevFaza 1
- Context Investigational Site, Grand Rapids
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Vključevanje udeležencevFaza 1
- START Midwest, Grand Rapids
A Study of YL242 in Subjects With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- US-206, Grand Rapids
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Vključevanje udeležencevOpazovalna študija
- Corewell Health, Grand Rapids
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Vključevanje udeležencev
- Mercy Health Saint Mary's, Grand Rapids
- Spectrum Health at Butterworth Campus, Grand Rapids
Študije za Rak (vse vrste) v drugih mestih
- Houston, TX121 študij
- New York City, NY109 študij
- Boston, MA85 študij
- Los Angeles, CA74 študij
- Nashville, TN65 študij
- Philadelphia, PA59 študij
- Washington, DC58 študij
- Durham, NC58 študij
- Chicago, IL51 študij
- Atlanta, GA49 študij
- Seattle, WA49 študij
- Arlington, VA48 študij
Druge študije v Grand Rapids
- Nemalicelični pljučni rak44 študij
- Kolorektalni rak40 študij
- Rak dojke26 študij
- Rak jajčnikov24 študij
- Metastatski rak22 študij
- Rak prostate19 študij
- Rak endometrija18 študij
- Rak želodca18 študij
- Rak trebušne slinavke18 študij
- Melanom17 študij
- Ploščatocelični karcinom glave in vratu15 študij
- Trojno negativni rak dojke15 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.